Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PharmaEssentia | Taiwan | Healthcare | Biotechnology & Medical Research | NT$216.65B | 162.6x | 0.89 | NT$657 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.7% Upside | Upgrade to Pro+ | |
Bora Pharmas | Taiwan | Healthcare | Pharmaceuticals | NT$73.56B | 22.7x | 1.71 | NT$733 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.8% Upside | Upgrade to Pro+ | |
Lotus Pharma | Taiwan | Healthcare | Pharmaceuticals | NT$67.49B | 16.6x | -1.12 | NT$264 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.9% Upside | Upgrade to Pro+ | |
Oneness Biotech | TPEX | Healthcare | Pharmaceuticals | NT$60.83B | -62.2x | NT$127.50 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Lumosa Therapeutics | TPEX | Healthcare | Biotechnology & Medical Research | NT$59.38B | -208.1x | 1.58 | NT$360 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -30.6% Downside | Upgrade to Pro+ | |
Polaris Group | Taiwan | Healthcare | Biotechnology & Medical Research | NT$37.88B | -19.3x | 0.28 | NT$54.80 | 7.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Center Laboratories | TPEX | Healthcare | Pharmaceuticals | NT$35.62B | -20.4x | 0.4 | NT$49.45 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pegavision | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$29.41B | 14.7x | 0.75 | NT$372 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.1% Upside | Upgrade to Pro+ | |
EirGenix | TPEX | Healthcare | Pharmaceuticals | NT$28.31B | -33.5x | 0.59 | NT$92.60 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.9% Upside | Upgrade to Pro+ | |
TaiMed Biologics | TPEX | Healthcare | Biotechnology & Medical Research | NT$22.28B | -192x | -4.37 | NT$81.60 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SPT | Taiwan | Healthcare | Pharmaceuticals | NT$19.02B | 47.2x | 0.92 | NT$23.95 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.4% Upside | Upgrade to Pro+ | |
Universal Vision BioTech | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$18.34B | 16.6x | 1.33 | NT$216.50 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.1% Upside | Upgrade to Pro+ | |
TTY Biopharm | TPEX | Healthcare | Pharmaceuticals | NT$18.23B | 16.2x | -24.57 | NT$73.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.4% Upside | Upgrade to Pro+ | |
Synmosa Biopharma | TPEX | Healthcare | Pharmaceuticals | NT$15.32B | 22.3x | 1.62 | NT$36.55 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.5% Downside | Upgrade to Pro+ | |
Y.S.H. | Taiwan | Healthcare | Pharmaceuticals | NT$15.18B | 14.4x | 0.31 | NT$57.60 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taidoc Tech | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$15.07B | 13.5x | -0.37 | NT$157.50 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.1% Downside | Upgrade to Pro+ | |
OBI Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$14.95B | -6.9x | 0.05 | NT$65.20 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sunmax BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$14.79B | 20.8x | 0.63 | NT$271.50 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaEngine | TPEX | Healthcare | Biotechnology & Medical Research | NT$14.37B | 40x | 2.07 | NT$100 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6% Upside | Upgrade to Pro+ | |
Excelsior | Taiwan | Healthcare | Healthcare Equipment & Supplies | NT$14.22B | 18.3x | 3.05 | NT$87.10 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.4% Downside | Upgrade to Pro+ | |
Medigen Vaccine Biologics | TPEX | Healthcare | Pharmaceuticals | NT$13.72B | -19.8x | -0.36 | NT$41.75 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gongwin Biopharm | TPEX | Healthcare | Biotechnology & Medical Research | NT$13.20B | -107.1x | -2.12 | NT$103.50 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CHO Pharma | TPEX | Healthcare | Pharmaceuticals | NT$11.81B | -44.5x | -1.5 | NT$55.20 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lin Bio | TPEX | Healthcare | Pharmaceuticals | NT$11.44B | -9.8x | 0.48 | NT$145.50 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
St.Shine Optical | TPEX | Healthcare | Healthcare Equipment & Supplies | NT$11.34B | 19.9x | -0.7 | NT$225 | 5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.3% Upside | Upgrade to Pro+ | |
SCPC | Taiwan | Healthcare | Pharmaceuticals | NT$11.31B | 13.2x | -15.83 | NT$63.80 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.8% Upside | Upgrade to Pro+ | |
Easywell Biomedical | TPEX | Healthcare | Pharmaceuticals | NT$11.19B | -75.9x | -17.75 | NT$91.80 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Formosa Lab | Taiwan | Healthcare | Pharmaceuticals | NT$10.94B | 42.7x | -0.61 | NT$91.90 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.5% Upside | Upgrade to Pro+ | |
SCI Pharmtech | Taiwan | Healthcare | Pharmaceuticals | NT$10.70B | 74.6x | -1.16 | NT$89.60 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Foresee Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$10.47B | -12.1x | -1.21 | NT$76.60 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |